Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). [Phase 3]
Phase 3 trial evaluating crenezumab in prodromal to mild Alzheimer's disease was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly [Phase 4]
Phase 4 trial update evaluating olfactory deficits and donepezil treatment in cognitively impaired elderly; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients [Phase 2]
Phase 2 trial evaluating GV1001 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial evaluating the safety, tolerability, and efficacy of Lecozotan SR in outpatients with Alzheimer's disease has completed phase…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial update evaluating flexible dosing of brexpiprazole for agitation in Alzheimer's disease; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 [Phase 2]
Phase 2 double-blind, placebo-controlled safety and efficacy study of NA-831 in cognitive impairment disorders has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Safety and Efficacy of Nabilone in Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update on nabilone for Alzheimer's disease evaluating safety and efficacy across Phase 2 and Phase 3.
-
CLINICAL_TRIALS research · 2020-06-18Clinical Trial Update: Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating the PLIE exercise program to prevent loss of independence in individuals with dementia, including A…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Pragmatic Trial of Video Education in Nursing Homes [NA]
A pragmatic trial evaluating video education in nursing homes has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation [Phase 3]
Phase 3 trial evaluating two fixed doses of brexpiprazole for agitation in Alzheimer's disease; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: An Open-Label Crenezumab Study in Participants With Alzheimer's Disease [Phase 3]
An open-label Phase 3 trial of crenezumab in participants with Alzheimer's disease was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia [Phase 2]
Phase II study of CPC-201 for Alzheimer's disease has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) [Phase 3]
Phase 3 open-label study of LMTM in Alzheimer's disease and behavioral variant frontotemporal dementia has been terminated; results posted i…
-
FDA approval · 2020-06-02FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for a generic memantine hydrochloride product.
-
FDA approval · 2020-05-28FDA Approved: TAUVID — Original Application (Eli Lilly and Company)
FDA approved Tauvid (flortaucipir F-18) for PET imaging to estimate tau neurofibrillary tangles in the brains of adult patients with known o…
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) [Phase 2, Phase 3]
The SNIFF study evaluating intranasal insulin for amnestic mild cognitive impairment and Alzheimer's disease has completed its Phase 2/3 por…
-
CLINICAL_TRIALS research · 2020-05-12Clinical Trial Update: Monetary Cost of Alzheimer's Disease in China
Clinical trial update assessing the monetary cost of Alzheimer's disease in China; completed with results posted in 2020.
-
CLINICAL_TRIALS research · 2020-05-05Clinical Trial Update: Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care [Phase 4]
A Phase 4 clinical trial investigating biomarkers of Alzheimer's disease and cognitive outcomes following perioperative care in patients wit…
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease [Phase 2]
Phase 2 clinical trial evaluating RPh201 for efficacy and safety in mild to moderate Alzheimer's dementia with or without cerebrovascular di…
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia [Phase 2]
Phase 2 clinical trial evaluating intepirdine (RVT-101) for gait and balance in dementia subjects has completed and results were posted.
-
FDA label_change · 2020-04-24FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for memantine hydrochloride filed by Unichem Pharmaceuticals (USA), Inc., updating the product label…
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease [Phase 3]
Phase 3 trial update for BPDO-1603 in moderate-to-severe Alzheimer's disease is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-04-17Clinical Trial Update: 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension [Phase 3]
Phase 3 open-label extension study of intepirdine (RVT-101) in Alzheimer's disease was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease [Phase 2]
Phase 2 trial update for intranasal glulisine in mild cognitive impairment and probable Alzheimer's disease has been terminated with results…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease [Phase 2]
Phase 2 trial investigating feasibility and effects of valaciclovir in early Alzheimer's disease and mild cognitive impairment.